Literature DB >> 16916756

More than structural cells, fibroblasts create and orchestrate the tumor microenvironment.

Carolyn J Baglole1, Denise M Ray, Steven H Bernstein, Steven E Feldon, Terry J Smith, Patricia J Sime, Richard P Phipps.   

Abstract

The tumor microenvironment comprises many cell types including infiltrating immune cells such as lymphocytes, endothelial cells and a complex stroma consisting mainly of fibroblasts. Fibroblasts are heterogeneous and consist of Thy-1+ and Thy-1- subsets that define different biosynthetic and differentiation potential. They produce mediators linked to carcinogenesis and metastasis, including Cox-2 and PGE2, both of which are also increased in most cancers. This review will highlight the emerging role of the complex fibroblastic stroma in establishing a microenvironment supporting malignant transformation, tumor growth and attenuation of host anti-tumor immune responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16916756     DOI: 10.1080/08820130600754960

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  47 in total

1.  Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors.

Authors:  Ann H Klopp; Yan Zhang; Travis Solley; Felipe Amaya-Manzanares; Frank Marini; Michael Andreeff; Bisrat Debeb; Wendy Woodward; Rosemarie Schmandt; Russell Broaddus; Karen Lu; Mikhail G Kolonin
Journal:  Clin Cancer Res       Date:  2011-12-13       Impact factor: 12.531

2.  Nemosis of fibroblasts is inhibited by benign HaCaT keratinocytes but promoted by malignant HaCaT cells.

Authors:  Kati Räsänen; Pertteli Salmenperä; Marc Baumann; Ismo Virtanen; Antti Vaheri
Journal:  Mol Oncol       Date:  2008-10-01       Impact factor: 6.603

Review 3.  Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise.

Authors:  M P Bernard; S Bancos; P J Sime; R P Phipps
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 4.  Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension.

Authors:  Kurt R Stenmark; Rubin M Tuder; Karim C El Kasmi
Journal:  J Appl Physiol (1985)       Date:  2015-04-30

5.  Perimysial fibroblasts of extraocular muscle, as unique as the muscle fibers.

Authors:  Linda L Kusner; Andrew Young; Steven Tjoe; Patrick Leahy; Henry J Kaminski
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-06       Impact factor: 4.799

6.  Lung-targeted overexpression of the NF-κB member RelB inhibits cigarette smoke-induced inflammation.

Authors:  David H McMillan; Carolyn J Baglole; Thomas H Thatcher; Sanjay Maggirwar; Patricia J Sime; Richard P Phipps
Journal:  Am J Pathol       Date:  2011-05-05       Impact factor: 4.307

7.  Ocular fibroblast diversity: implications for inflammation and ocular wound healing.

Authors:  Xia Xi; David H McMillan; Geniece M Lehmann; Patricia J Sime; Richard T Libby; Krystel R Huxlin; Steven E Feldon; Richard P Phipps
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-01       Impact factor: 4.799

8.  T cells and stromal fibroblasts in human tumor microenvironments represent potential therapeutic targets.

Authors:  Jennifer L Barnas; Michelle R Simpson-Abelson; Sandra J Yokota; Raymond J Kelleher; Richard B Bankert
Journal:  Cancer Microenviron       Date:  2010-03-31

9.  Transient tumor-fibroblast interactions increase tumor cell malignancy by a TGF-Beta mediated mechanism in a mouse xenograft model of breast cancer.

Authors:  Christina H Stuelten; Johanna I Busch; Binwu Tang; Kathleen C Flanders; Akira Oshima; Emily Sutton; Tatiana S Karpova; Anita B Roberts; Lalage M Wakefield; John E Niederhuber
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

10.  The aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2 and prostaglandin production in lung fibroblasts through regulation of the NF-kappaB family member RelB.

Authors:  Carolyn J Baglole; Sanjay B Maggirwar; Thomas A Gasiewicz; Thomas H Thatcher; Richard P Phipps; Patricia J Sime
Journal:  J Biol Chem       Date:  2008-08-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.